First-Voided Urinary LH vs. GnRH-stimulation in Differentiating Slowly- From Rapidly Progressive-Precocious Puberty
NCT01800565 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65
Last updated 2013-02-27
Summary
Precocious puberty (PP) in girls is classically defined by the onset of secondary sexual characteristics before eight years of age, but subsequent pubertal maturation can be quite varied. In many girls, PP takes a rapid course of progression (rapidly progressive precocious puberty; RP-PP) with an early menarche and fusion of the epiphyseal growth plates, leading eventually to a reduced final height if not treated. In a subset of girls with PP however, the growth rate slows to normal for age, skeletal maturation progresses in accordance with chronological age and there is little to no risk of impairment of final height (slowly progressive precocious puberty; SP-PP). Other conditions of non-progressive PP include premature breast budding and unsustained PP that is characterized by a spontaneous regression of sexual precocity. Due to their benign course, slowly progressive (SP) PP and other non-progressive forms of PP do not warrant therapy with GnRH agonists. Differentiating these forms from RP-PP is therefore essential to prevent unnecessary intervention in a population that accounts for at least 50% of girls with PP. A distinction between these forms of PP may be difficult on clinical grounds however, since all these patients may present initially as isolated breast development.
The gold standard for the diagnosis of true (central) PP is the measurement of gonadotropins following GnRH stimulation test. There is however an overlap between prepubertal and early pubertal values and between girls with premature breast budding and progressive PP. It was suggested therefore that progressive pubertal development and growth acceleration should be documented over a 3- to 6-months period before GnRHa therapy in initiated.
More than a decade ago several studies demonstrated that urinary gonadotropins are age related and significantly increased during puberty. It has been suggested that urinary gonadotropins measurements can be used for differential diagnosis of pubertal disorders. This is based on the assumption that gradual elevation of nocturnal LH secretion prior to and at the onset of puberty can be reflected by first-voided urinary LH (ULH). In this prospective study, the investigators aimed to evaluate the value of first-voided ULH measurements in predicting pubertal course and differentiating SP-PP from RP-PP, by comparison to GnRH-stimulated gonadotropins.
Conditions
- Precocious Puberty, Gonadotropin-dependent
Interventions
- OTHER
-
Measurement of LH in first-voided urine
participants in this study will be studied by the standard GnRH stimulation test. In addition, they will provide first voided urine sample (the experimental part)for the measurement of LH.
- OTHER
-
collection of first-voided urine sample for LH level
participants in this study will be studied by the standard GnRH stimulation test. In addition, they will provide first voided urine sample (the experimental part)for the measurement of LH.
Sponsors & Collaborators
-
Amnon Zung
lead OTHER
Principal Investigators
-
Amnon Zung, MD · Pediatirc Endocrinology Unit, Kaplan Medical Center, affiliated with the Hebrew University of Jerusalem, Israel
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Max Age
- 9 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-06-30
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Follicle-Stimulating Hormone (FSH) and the Onset of Puberty
NCT00734279 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
NCT03068910 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
NCT00929006 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
NCT01425541 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency
NCT06851754 ·Status: RECRUITING ·Phase: PHASE3
-
Pulsatile GnRH in Anovulatory Infertility
NCT00383656 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.
NCT00334425 ·Status: UNKNOWN ·Phase: PHASE4
-
GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT
NCT03039049 ·Status: COMPLETED ·Phase: PHASE3
-
Low-dose GH Supplementation Increases Clinical Pregnancy Rate
NCT02359695 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
NCT01428245 ·Status: TERMINATED ·Phase: NA
-
The Use of GnRH Agonist Trigger in the Prevention of OHSS
NCT00349258 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
NCT01428193 ·Status: TERMINATED ·Phase: NA
-
GnRH Agonist for Luteal Phase Support.
NCT05484193 ·Status: UNKNOWN ·Phase: NA
-
Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients
NCT01683513 ·Status: COMPLETED ·Phase: PHASE4
-
Hormonal Regulation of Puberty and Fertility
NCT01511588 ·Status: COMPLETED
-
LutrePulse Hypogonadotropic Hypogonadism
NCT01976728 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Effects of Progesterone on LH Pulses During the Follicular Phase (CRM006)
NCT01602679 ·Status: TERMINATED ·Phase: PHASE1
-
LH Hormone Pulsation in the Luteal Phase in GnRH Antagonist IVF Cycles Triggered by GnRH Agonist for Final Oocyte Maturation
NCT02449642 ·Status: COMPLETED
-
Human Chorionic Gonadotropin (hCG) Test: A Novel Method to Evaluate the Ovarian Reserve
NCT00646568 ·Status: COMPLETED ·Phase: NA
-
Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG
NCT01638026 ·Status: COMPLETED ·Phase: PHASE4
-
GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT
NCT02053779 ·Status: COMPLETED ·Phase: PHASE3
-
Earlier Triggering in Rec-FSH/GnRH Antagonist Cycles
NCT01390207 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS
NCT02801565 ·Status: UNKNOWN ·Phase: NA
-
Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS
NCT02827656 ·Status: UNKNOWN ·Phase: NA
-
Severe LH Suppressed Patients After Administration of a GnRH Antagonist
NCT01936077 ·Status: COMPLETED ·Phase: PHASE4